DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Muss HB, Case LD, Atkins JN, Bearden JD, Cooper MR, Cruz JM, Jackson DV, O'Rourke MA, Pavy MD, Powell BL, Richards F, Spurr CL, Eagle K, White DR.
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: A Piedmont Oncology Association Study.
J Clin Oncol 1994; 12: 1630-1638
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.